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Abstract 
Background: Methadone is a synthetic opioid and receptor agonist morphine; thus, its consumption has the 
effects and side effects of opioid. Methadone maintenance treatment (MMT) is used as an alternative 
treatment for people who are suffering from substance abuse and do not have the ability to withdraw. Despite 
its benefits, this drug also has side effects. The purpose of this study was to investigate the effects of 
methadone treatment on sexual function, sleep, and weight after 6 months. 
Methods: The study subjects consisted of 200 patients who had referred to the Methadone Clinic of Shahid 
Beheshti Training Hospital, Kerman, Iran, during a 6-month period and were treated using MMT. Data 
collection tools consisted of the demographic questionnaire, Pittsburgh sleep quality index (PSQI), and 
Arizona sexual experience scale (ASEX). The questionnaires were completed by the participants before and 6 
months after the treatment. 
Findings: The results of this study showed that methadone consumption has significant effects on sexual 
dysfunction, sleep disorders, and weight gain. 
Conclusion: The consideration of the side effects of MMT can result in consumers’ commitment to the 
treatment. 
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Introduction 
Methadone is a synthetic narcotic substance and a 
mu receptor agonist. Its intake causes satisfaction 
and has an analgesic effect and other effects of 
morphine-like substances.1 Due to its 2 features of 
long half-life and high oral absorption, 
methadone is used as an alternative treatment to 
prevent or reduce withdrawal symptoms in the 
treatment of drug abuse.2 Methadone 
maintenance treatment (MMT) is used in addicts 
who are not able to maintain a constant 
abstinence from drugs. Using this method of 
treatment the craving for drugs is resolved in 
these patients. However, psychological 
dependence to heroin can be gradually 
overcome.3 Refusal of injection and the prevention 
of risky behaviors, and returning to work, 
community, and family is a major goal of public 
health and is expected with MMT.4 The purpose 
of this study was to investigate the effects of 
methadone treatment on sexual function, sleep, 
and weight after 6 months of use. 
MMT is a continuity of a kind of addiction, 
and despite its proven success in many countries, 
its careless and irresponsible prescription can 
cause serious danger. Methadone has a low 
therapeutic index, meaning that the medication 
dose required for treatment is very close to the 
toxic dose. In particular, its use in combination 
with other drugs has potential risks.5  
In addition, MMT can have some side effects. 
Drowsiness, opioid craving, constipation, dental 
problems, weight gain, sleep disturbance, 
decreased libido, nausea and vomiting, irregular 
menstruation, excessive sweating, dizziness, 
blurred consciousness, rash, loss of appetite, 
irritability, and weakness are some side effects of 
methadone.3 Some of these side effects, like 
nausea and drowsiness, abate within the first 
weeks of treatment, but some side effects, such as 
constipation, excessive sweating, and reduced 
libido or sexual dysfunction, persist for months.6  
Sexual disorders are major barriers to 
commitment to continuing maintenance treatment 
with opioid pharmaceutical compounds 
especially in patients who are treated with high 
doses or for prolonged periods.7 In his research, 
Kreek concluded that in patients undergoing 
MMT, the side effects of sweating, constipation, 
sexual dysfunction, and sleep and appetite 
disorders may emerge or persist from 6 months to 
3 years after treatment.8 
Babakhanian et al., in their study on men 
under MMT, found that after 6 months of 
treatment patients showed moderate 
improvement in erectile function, complete 
improvement regarding sexual intercourse, and 
partial improvement regarding sexual desire, but 
no improvement in orgasmic function.9 The 
results of the study by Ramazanzadeh et al. in 
Sanandaj, Iran, showed a significant improvement 
in patients’ marital satisfaction after 7 months of 
treatment with methadone.10 
The study by Sadeghpour et al. on patients 
undergoing MMT in Tehran, Iran, showed that 
patients who had been treated for more than 6 
months had more satisfactory quality of life and 
sleep compared to those who were new to the 
treatment, or had been previously treated and had 
relapsed.11 The study by Peles et al. conducted on 
23 patients undergoing MMT showed no 
significant change regarding sleep during 6-12 
months of follow-up, but weight gain in a small 
group of patients increased sleep apnea.12 Mysels 
et al. Performed a comparative study on 
methadone and naltrexone. Methadone is a mu 
receptor agonist which causes weight gain and 
naltrexone is a mu receptor agonist which causes 
weight loss; however, no significant differences 
were observed between the two and in 
comparison to the baseline condition.13  
Due to the expansion of MMT centers, the 
consideration of the complications of MMT can be 
effective in the increasing or continuation of MMT 
in order to achieve benefits. In the present study, 
the prevalence of sexual dysfunction, and sleep 
and appetite disorders were investigated on 
patients who referred to the Methadone Clinic of 
Shahid Beheshti Training Hospital, Kerman, Iran. 
The results of this study, in addition to clarifying 
the aspects or effects of this treatment, could be a 
prelude to future interventions to reduce 
morbidity and increase patients’ continuation of 
treatment, and thus, the improvement of their 
quality of life and public health. 
Methods 
This was a cross-sectional study. The study 
population consisted of all 200 patients who had 
undergone MMT within a 6 month period in 2013 
at the Shahid Beheshti Training Hospital in 
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Kerman. The subjects were selected via 
convenience sampling method. During admission, 
the demographic questionnaire, Pittsburgh sleep 
quality index (PSQI), and Arizona sexual 
experience scale (ASEX) were completed for all 
participants. Moreover, the patients were weighed 
at the beginning of treatment. The study was 
explained to them and they were reassured 
regarding the confidentiality of their information. 
After 6 months, the questionnaires were 
completed again by the patients. They were also 
asked about night sweats and lack of appetite.  
Exclusion criteria included inability to 
understand the questions, history of 
hospitalization at a psychiatric hospital except for 
withdrawal, diabetes, epilepsy, high blood 
pressure and use of anti-hypertensive drugs, and 
use of antidepressants, tranquilizers, 
anticholinergic drugs, and antipsychotics. The 
Persian version of the PSQI had a 0.77 Cronbach's 
alpha coefficient, score range of 0-21 and cut-off 
point of 5.11,14 The Persian translation of the ASEX 
had a Cronbach’s alpha of 9%, a good reliability, 
and a correlation coefficient of 0.80.15 Data 
analysis was performed using SPSS software 
(version 20, SPSS Inc., Chicago, IL, USA) and after 
determining the descriptive measures of central 
tendency and dispersion. Repeated measure was 
used to investigate the effects of methadone on 
sexual function, sleep, and weight over time and 
the impact of the gender factor. 
 
Results 
In this study, 200 patients were evaluated. Due to 
the withdrawal of one case, 199 patients were 
analyzed, including 180 male patients (90.5%) and 
19 female patients (9.5%). Among the participants, 
39 were single (19.6%), 158 were married (79.4%), 
and 2 were divorced (1.0%). In terms of education, 
11 patients were illiterate (5.5%), 38 patients had 
primary education (19.1%), 79 patients were 
under diploma (39.7%), 40 patients had diploma 
(20.1%), and 31 patients had university education 
(15.6%). Table 1 shows the demographic 
characteristics of the participants. The addiction 
status of the participants was as follows: 9 
patients had heroin addiction (4.5%), 4 patients 
had glass addiction (2.0%), 33 patients had opium 
sap addiction (16.6%), 1 patient had crystal 
addiction (0.5%), 13 patients had opium addiction 
(6.6%), and 139 patients had addiction to two or 
more substances (69.8%). The minimum dose of 
methadone was 30 mg and maximum dose was 
140 mg.  
Night sweating was mentioned by 29 patients 
(14.6%) and lack of appetite in 26 cases (13.1%). 
The results showed that methadone had a 
significant effect on sexual function of the 
consumers (P < 0.001). Therefore, methadone 
caused sexual dysfunction in the patients and this 
effect was not significantly different in males and 
females (P = 0.100) (Table 1). Table 2 illustrates the 
effect of methadone on each sexual stage. 
Table 1. Mean changes of sexual function, sleep, and weight after 6 months of MMT (methadone maintenance treatment) 
Variable Gender Number Baseline mean Mean after 6 months of treatment P 
Sexual dysfunction 
Male 180 16.45 18.33 
< 0.001 Female 19 17.11 17.79 
Total 199 16.51 18.28 
Sleep disorder 
Male 180 7.58 7.94 
< 0.001 Female 19 7.00 7.95 
Total 199 7.52 7.94 
Weight change 
Male 180 63.23 65.13 
< 0.001 Female 19 59.21 61.05 
Total 199 62.84 64.74 
 
Table 2. Mean changes of the ASEX (Arizona sexual experience scale) scores with regards to 
sexual stages after 6 months of MMT (Methadone maintenance treatment) 
Sexual stages Before MMT After MMT 
Mean ± SD Mean ± SD 
Sexual desire 3.2 ± 1.01 3.7 ± 1.0 
Excitement 6.9 ± 1.9 7.1 ± 1.9 
Orgasm 6.5 ± 1.9 7.5 ± 1.8 
MMT: Methadone maintenance treatment; SD: Standard deviation 
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Discussion 
This study was conducted on 199 patients who 
underwent MMT. The incidence of sexual 
dysfunction and sleep disorders had significantly 
increased with methadone (P < 0.001). Their weight 
had also significantly increased after receiving 
MMT (P < 0.001). These changes were not 
associated with the gender of the patients. The 
complications of the medications were due to lack 
of commitment to the treatment. Sexual 
dysfunction was a barrier to commitment to 
continuing maintenance therapy with opioid 
componds.7 Some side effects abate within the first 
weeks of treatment which is a sign of physiological 
adaptations to the effects of the medication. Some 
of the side effects, such as constipation, excessive 
sweating, and sexual dysfunction, persisted for 
months during MMT.6 
The results of the present study were consistent 
with that of other studies on MMT. In the study by 
Kreek, the rate of sexual dysfunction in the 
participants was similar to that in the general 
population, but the rate of orgasmic disorders was 
higher which may respond to the reduction of 
dose.8 In the study by Kheirabadi et al., the 
majority of the subjects in the study (94.8%) had 
sexual dysfunction, ranging from mild to severe, 
and this had a significant relationship with 
prolactin blood levels.16 In the study by 
Roshanpajhu et al.17 in Tehran a reduction in sexual 
desire was also observed which was consistent 
with the present study. Nevertheless, the results of 
this study were inconsistent with some previous 
studies. Including the study by Babakhanian et al. 
which showed a moderate improvement in erectile 
function and sexual function after maintenance 
treatment.9 
Furthermore, the results of this study were 
inconsistent with that of Ramazanzadeh et al. 
regarding improvement in marital satisfaction after 
treatment, which could be related to differences in 
study methods.10 The results of this study were in 
consistent with that of Peles et al. regarding sleep 
quality of patients treated with methadone 
maintenance.12 The strength of the present study 
was its larger sample size compared to the 
mentioned study. Weight gain was observed in a 
small number of patients in the study by Peles  
et al.6 The present study results regarding weight 
changes were also different from Mysels et al. 
study.13 That study had a smaller sample size 
compared to the present study. The social life 
improvement of the patients was possibly the 
reason for their weight gain as a positive factor 
during MMT in the present study.13  
The side effects of MMT, in comparison to its 
public health benefits and focus on reduction of 
harm, are justifiable. Furthermore, the 
disagreement between the results of the present 
study and other studies may be due to the different 
variables addressed in different studies, including 
quality of life and improving family relationships, 
which may affect the outcome of the research.  
Addiction has different aspects, and thus, 
extensive research is necessary regarding various 
factors and comparative methods in the normal 
population and people who continue substance 
abuse. Lack of available studies on the effects of 
methadone, its growing use, and MMT justify the 
need for further studies in this field. 
Conclusion 
This study showed that, despite the benefits of 
methadone in reducing damage, and hence, 
promoting health, it can have complications such 
as sleep disorders, sexual dysfunction, and weight 
gain which can create obstacles for its use. Paying 
attention to these side effects and trying to control 
them can be effective in the consumers’ 
commitment to the treatment. 
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